9-86303162-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024617.4(TUT7):c.4018C>G(p.Leu1340Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024617.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUT7 | ENST00000375963.8 | c.4018C>G | p.Leu1340Val | missense_variant | Exon 25 of 27 | 5 | NM_024617.4 | ENSP00000365130.3 | ||
TUT7 | ENST00000375960.6 | c.3310C>G | p.Leu1104Val | missense_variant | Exon 18 of 20 | 1 | ENSP00000365127.2 | |||
TUT7 | ENST00000277141.10 | c.1885C>G | p.Leu629Val | missense_variant | Exon 26 of 28 | 2 | ENSP00000277141.6 | |||
TUT7 | ENST00000375957.5 | c.718C>G | p.Leu240Val | missense_variant | Exon 10 of 12 | 2 | ENSP00000365124.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.4018C>G (p.L1340V) alteration is located in exon 25 (coding exon 24) of the ZCCHC6 gene. This alteration results from a C to G substitution at nucleotide position 4018, causing the leucine (L) at amino acid position 1340 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.